Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients

被引:148
作者
Lee, Kyung-Yul [1 ]
Han, Sang Won [1 ]
Kim, Seo Hyun [1 ]
Nam, Hyo Seok [1 ]
Ahn, Sung Whan [1 ]
Kim, Dong Joon [1 ]
Seo, Sang Hyun [1 ]
Kim, Dong Ik [1 ]
Heo, Ji Hoe [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Neurol, Natl Core Res Ctr Nanomed Technol, Seoul 120752, South Korea
关键词
CT angiography; thrombolysis; tissue plasminogen activator;
D O I
10.1161/01.STR.0000251788.03914.00
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Recanalization rates after the intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment have been poorly studied in acute stroke. Methods-CT angiography was performed before IV rt-PA in all patients and digital subtraction angiography was undertaken for intra-arterial thrombolysis in cases of no improvement after rt-PA infusion. Results-Forty-five patients were treated with IV rt-PA. Initial CT angiography showed relevant arterial occlusions in 35 patients. Recanalization after rt-PA therapy was demonstrated by digital subtraction angiography in 7 of the 31 patients with the occlusion on initial CT angiography: 2/16 in the internal carotid or proximal middle cerebral artery, 3/11 in the distal middle cerebral artery and 2/4 in the basilar artery occlusion. Conclusions-The early recanalization rate after IV rt-PA use was very low in cases with large proximal arterial occlusions. CT angiography before IV rt-PA may be useful for the prediction of its efficacy.
引用
收藏
页码:192 / 193
页数:2
相关论文
共 8 条
[1]   Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke [J].
Alexandrov, AV ;
Molina, CA ;
Grotta, JC ;
Garami, Z ;
Ford, SR ;
Alvarez-Sabin, J ;
Montaner, J ;
Saqqur, M ;
Demchuk, AM ;
Moye, LA ;
Hill, MD ;
Wojner, AW ;
Al-Senani, F ;
Burgin, S ;
Calleja, S ;
Campbell, M ;
Chen, CI ;
Chernyshev, O ;
Choi, J ;
El-Mitwalli, A ;
Felberg, R ;
Ford, S ;
Garami, Z ;
Irr, W ;
Grotta, J ;
Hall, C ;
Iguchi, Y ;
Ireland, J ;
Labiche, L ;
Malkoff, M ;
Morgenstern, L ;
Noser, E ;
Okon, N ;
Piriyawat, P ;
Robinson, D ;
Shaltoni, H ;
Shaw, S ;
Uchino, K ;
Yatsu, F ;
Alvarez-Sabín, J ;
Arenillas, JF ;
Huertas, R ;
Molina, C ;
Montaner, J ;
Ribó, M ;
Rubiera, M ;
Santamarina, E ;
Saqqur, M ;
Alchtar, N ;
O'Rourke, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2170-2178
[2]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[4]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[5]   Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke [J].
Higashida, RT ;
Furlan, AJ .
STROKE, 2003, 34 (08) :E109-E137
[6]   Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion [J].
Kim, YS ;
Garami, Z ;
Mikulik, R ;
Molina, CA ;
Alexandrov, AV .
STROKE, 2005, 36 (04) :869-871
[7]  
Lee KY, 2004, AM J NEURORADIOL, V25, P1470
[8]   SAFETY AND EFFICACY OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND HEPARIN IN ACUTE MIDDLE CEREBRAL-ARTERY STROKE [J].
VONKUMMER, R ;
HACKE, W .
STROKE, 1992, 23 (05) :646-652